Ocean Biomedical
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ocean Biomedical generated cash of -$9,429,000, which is less than the previous year. Cash used in financing activities reached the amount of $10,399,000 last year. Net change in cash is therefore $970,000.

Cash Flow

Ocean Biomedical, Inc. (NASDAQ:OCEA): Cash Flow
2019 0 0 0
2020 -64K 0 64K
2021 -1.05M -107.1M 1.11M
2022 -747.29K -2.1M 2.1M
2023 -9.42M 0 10.39M

OCEA Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
34K60K000
Operating activities
Net income
-114.46M-958.43K-62.34M-1.65M-232K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
00000
Stock-based compensation expense
1.20M056.55M00
Deferred income tax benefit 1.20M056.55M00
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
1.23M290.38K000
Cash generated by operating activities
-9.42M-747.29K-1.05M-64K0
Investing activities
Purchases Of Investments
00-107.1M00
Investments In Property Plant And Equipment
0-3000
Acquisitions Net
00000
Cash generated by investing activities
0-2.1M-107.1M00
Financing activities
Common Stock Issued
15.76M01.01M00
Payments for dividends
00000
Repurchases of common stock
-64.28M0000
Repayments of term debt
6.80M2.1M000
Cash used in financing activities
10.39M2.1M1.11M64K0
Net Change In Cash
970K-747.29K60K00
Cash at end of period
1.00M328.30K60K00